Plano, Texas is gearing up to welcome a significant new player in the biotechnology sector as NTxBio, commonly known as NTx, announces the establishment of a new biomanufacturing facility in the city. According to an announcement by Governor Greg Abbott and subsequent reporting by the Office of the Texas Governor, the move is projected to generate over 170 new jobs and spur more than $31 million in capital investment. Bolstering this growth, the state has provided a Texas Enterprise Fund (TEF) grant amounting to $1,479,000 to support NTx's development.
Founded back in 2015, NTx has established itself by cornering the market, manufacturing pharmaceutical-grade materials essential for RNA and protein therapeutics development. With the establishment of their Plano facility, NTx is set to tap into Texas' rich pool of talent, with Governor Abbott celebrating the state as "the epicenter for groundbreaking, life-saving medical research" and a beehive for biotech firms. NTx's President and CEO Dr. Jamie Coffin shared the excitement, stating, "We are thrilled to expand into our new facility in Plano," as reported by the Governor's Office. The company's synthesis of cutting-edge biomanufacturing platforms is aimed in part to reinforce the healthcare industry in the state.
Not only politicians but also local leaders are underlining the impact NTx's decision will have on the region. Senator Angela Paxton believes that the investment will "advances cutting-edge medical research that will benefit not just our region, but patients across the globe," as said in the statement obtained by the Governor's Office. Representative Katrina Pierson also underscored the positive effects on the local economy, anticipating new job creation and enhanced research capabilities. Plano Mayor John B. Muns and City of Plano Director of Economic Development Doug McDonald both echoed the sentiment, exalting the city as a hub for innovation, especially within the life sciences sphere.
While operational details about the facility remain scant, the community's expectations are high. This facility is predicted, using domestically produced raw materials, to spur advancements in treatments for cancer and rare diseases. Mayor Muns pointed to Plano's corporate innovation ecosystem as being ideally poised to foster the type of growth NTx is pursuing with its new R&D lab. The addition of NTx to Plano is seen as another significant move illustrating Texas’ commitment to leading in biotech research and development, a step forward that may, as officials have claimed, revolutionize both the discovery and production of biologic materials.
